MedCodeSearch
HCPCS Level II Historical

Q0519

Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

Historical code

This code is not active in the current release.

See the full version history

Release
October 2026
Effective
Official source (opens in a new tab)

Official Coding Notes

Reproduced verbatim from the October 2026 HCPCS Level II files.

Note

MMA section 303(e).

Version History

How Q0519 appears in each release imported from the official files, newest first.

  1. October 2026 Effective

    Inactive

    Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

  2. July 2026 Effective

    Inactive

    Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

  3. April 2026 Effective

    Inactive

    Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

  4. January 2026 Effective

    Inactive

    Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

Data Source

Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.

Release
October 2026
Effective
Source file
october-2026-alpha-numeric-hcpcs-file.zip

Official HCPCS Level II source files (opens in a new tab)

MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.

Look up another code

Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.